Dr. Andrew Feigin shows his colleague Jean Ayan one of the cognitive tests he administers for the Neuroscience Experimental Therapeutics (NET) unit at The Feinstein Institute for Medical Research, while their colleague Barbara Shannon looks on.
The Neuroscience Experimental Therapeutics (NET) unit within the Movement Disorders Center and The Feinstein Institute for Medical Research (FIMR) conducts all clinical trials for Parkinson’s disease and other movement disorders. The unit was established by Dr. Andrew Feigin in 1996 and is located in a 1,000-square-foot space within FIMR, adjacent to the Functional Brain Imaging Laboratory. The proximity of the NET unit to the imaging center facilitates interactions between the groups; in fact, the two groups function as two parts of a whole clinical research unit. NET unit facilities include office space, computers, and copy/fax/printers for two nurse coordinators, two examination rooms, two neurocognitive testing rooms, a secure medication room, clean and soiled utility rooms, a phlebotomy room with refrigerated centrifuge, refrigerator and freezer storage, and locked data/CRF storage.